Relative Strength Chart Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.16 USD | -0.49% |
|
+1.60% | +14.26% |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| Jul. 13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | -0.49% | +1.60% | +14.26% | +28.70% | -42.04% | 11.04B |  | | |
- Stock Market
- Stocks
- CRL Stock
- Charts Charles River Laboratories International, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
